Analyst Ratings Network.com reported that Boston Scientific has received a consensus rating of “buy” from 24 research firms.
Check-Cap, a capsule endoscopy developer, named William Densel as CEO and director.
Three analyst firms have given EndoChoice stock a $23.33 price target in the short term, according to an OTC Outlook report.
Inc. 500 released its 2015 list, which names the fastest-growing private companies in the country. Modernizing Medicine, the developer of the Electronic Medical Assistant, was named to the list. EMA Gastro is among the company’s offerings.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on gastroenterology:
EndoChoice ships 27 Fuse systems in Q2, FDA approves ORBERA device for obesity treatment & more – 4 GI/endoscopy company key notes
8 payment updates for gastroenterologists to know
NJ Digestive Health Center wins innovation award
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
